BioDelivery Sciences International of Morrisville has registered into a clinical development and license agreement with Clinical progress to maturity Capital of Princeton.
BioDelivery Sciences International of Morrisville has registered into a clinical development and license agreement with Clinical progress to maturity Capital of Princeton, N.J., in which it will receive up to $7 million in funding for Phase III clinical trials of its BEMA[TM] Fentanyl crops for the treatment of cancer pain.
COPYRIGHT 2005 North Carolina Biotechnology Center